GuideWell Innovation Selects Six Women-founded Health Tech Companies for Summer Scale-Up Accelerator Cohort
ORLANDO, FL. – GuideWell Innovation Selects Six Women-founded Health Tech Companies for Summer Scale-Up Accelerator Cohort GuideWell Innovation, in affiliation with Springboard Enterprises, has selected six health technology companies for the Summer 2019 GuideWell Scale-Up Accelerator cohort. The GuideWell Scale-Up Accelerator is an eight-week technology accelerator program focused on “Scale-Up” health technology or medical device companies. This cohort is dedicated to companies with women founders that are headquartered in the southeastern U.S. The southeastern U.S. lags other...
Read MorePiedmont Triad honors ‘Body-on-a-Chip’ team, life science leaders at BioNight
GREENSBORO, N.C. – Some of the Piedmont Triad region’s most successful individuals and organizations working in the biosciences have been honored with Excellence Awards. The awards were given at Triad BioNight, a celebration of the region’s life science sector organized by the Piedmont Triad Office of the North Carolina Biotechnology Center. More than 300 people attended the networking and awards event June 20 at the Grandover Resort and Conference Center in Greensboro. The honorees are: Yonnie Butler Yonnie D. Butler, executive director of the Biotechnology Center of...
Read MoreSNP Therapeutics merges gene testing with personalized nutrition
RESEARCH TRIANGLE PARK, N.C. – In what may be the ultimate affirmation of “you are what you eat,” an innovative Charlotte-area company is merging high-tech genomic testing with personalized nutritional formulations to treat individual medical conditions. The company, SNP Therapeutics (pronounced “snip”), was formed a year ago in labs at the North Carolina Research Campus (NCRC) in Kannapolis. It applies high-tech analysis of patients’ genomes to identify genetic variants that cause disease – genetic misspellings technically known as single nucleotide polymorphisms, or...
Read MoreTriangle pharma brings in new CFO looking for capital
RALEIGH, N.C. – Amidst a continued effort to expand, Innovate BioPharmaceuticals has brought on a full-time chief financial officer, which it hopes will lead a push to raise more capital to finance its clinical trials and pipeline. The Raleigh-based company (Nasdaq: INNT) just recently launched its Phase 3 trials of its lead candidate N-202 – a treatment for celiac disease and the first drug in history of the disease to make it to a Phase 3 trial. The trial launch came after a long year of capital raises and deals, but the company has now brought on a former Cancer...
Read MoreThermo Fisher’s Brammer Bio Completing $100M in Expansion Projects
ALACHUA, FL. – Thermo Fisher Scientific says its recently-acquired Brammer Bio is completing $100 million in capital expansion projects, as the viral vector contract development and manufacturing organization (CDMO) looks to satisfy growing demand for gene therapies for clinical and commercial use. In Alachua, FL, Brammer has added new quality control laboratories, and later this year will bring on an additional process development laboratory and expanded warehouse capacity. Brammer’s Alachua facility is an 80,000-square-foot early clinical campus consisting of three buildings: a...
Read MoreImmunotherapy firm Dualogics, South Korea biotech partner to target cancer
DURHAM, N.C. – Durham immunotherapy company Dualogics has entered into a collaboration agreement with South Korea’s Y-Biologics to use their combined expertise to discover and develop novel cancer antibodies. Antibodies are Y-shaped proteins produced mainly by plasma cells that circulate throughout our bodies, in our bloodstreams. The “Y” shape of the proteins resulted in the company name Y-Biologics — and, as you can see, the logos of both companies. These antibody proteins are tools used by our bodies’ immune systems to fight off invaders such as unwanted bacteria,...
Read More
Follow Us!